Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 372-377

  Shiffman, Mitchell L ^a   Luketic, Velimir A ^a   Sanyal, Arun J ^a   Thompson, Eric B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Hepatitis; Lidocaine; Monoethylglycinexylodide

Indexed keywords

LIDOCAINE;

CHRONIC LIVER DISEASE; CONFERENCE PAPER; DOSE LIVER FUNCTION RELATION; DRUG LIVER LEVEL; DRUG MONITORING; HEPATITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER METABOLISM; PRIORITY JOURNAL;

ANESTHETICS, LOCAL; CHRONIC DISEASE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; VARIATION (GENETICS);

EID: 0029839832     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00010     Document Type: Conference Paper

References (19)

1. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter, randomized, controlled trial. N Engl J Med 1989;321:1501-6.
2. Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 1990:323:295-301.
3. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
4. Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C virus. Am J Gastroenterol 1995;90:1250-7.
5. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short term survival among cirrhotics. Hepatology 1987;7:660-4.
6. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and a test of hepatic function. Clin Sci 1961;21: 43-57.
7. Bargetzi MJ, AoyamaT, Gonzalez FJ, Meyer UA. Lidocaine metabolism in human liver microsomes by cytochrome P450-IIIA4. Clin Pharmacol Ther 1989;46:521-7.
8. Shiffman ML, Luketic VA, Sanyal AJ, et al. Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology 1994;19:933-40.
9. Shiffman ML, Fisher RA, Sanyal AJ, et al. Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation. Transplantation 1993;55:830-4.
10. Oellerich M, Raude E, Burdelski M, et al. Monoethylglycinexylodide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987;25: 845-53.
11. Wyman MG, Lalka D, Hammersmith L, Cannom DS, Goldreyer BN. Multiple bolus technique for lidocaine administration during the first hours of a myocardial infarction. Am J Cardiol 1978;41:313-7.
12. Arrigoni A, Gindro T, Aimo G, et al. Monoethylglycinexylodide test: aprognostic indicator of survival in cirrhosis. Hepatology 1994;20:383-7.
13. Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayer R. Predictors of one-year pre-transplant survival in patients with cirrhosis. Hepatology 1991;14:1029-34.
14. Schroeder TJ, Gremse DA, Mansour ME, et al. Lidocaine metabolite formation as an index of liver function in hepatic transplant donors and recipients. Transplant Proc 1989;21: 2299-301.
15. Huang YS, Lee SD, Deng JF, et al. Measuring lidocaine metabolite-monoethylglycinexylodide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol 1993;19:140-7.
16. Taliani G, Duca F, Lecce R, Livoli D, Pasquazzi C, De Bac C. Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis. Hepatology 1995;21: 1760-1.
17. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. J Clin Invest 1989;83:688-97.
18. Oellerich M, Schutz E, Polzien F, et al. Influence of gender on the monoethylglycinexylodide test in normal subjects and liver donors. Ther Drug Monit 1994;16:225-31.
19. Rossi SJ, Schroeder TJ, Vine WH, et al. Monoethylglycinexylodide formation in assessing pediatric donor liver function. Ther Drug Monit 1992;14:452-6.